Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ahern

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|August 1, 1979
Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disordersB Cooper, D Ahern
The Journal of Experimental Biology|July 9, 2003
Regulation of urine reprocessing in the maintenance of sodium and water balance in the terrestrial Christmas Island red crab Gecarcoidea natalis investigated under field conditionsStephen Morris, Mark D Ahern
International Archives of Allergy and Immunology|May 1, 1995
Expression of the CD40 ligand in T lymphocytes and induction of IgE isotype switchingR Fuleihan, D Ahern, R S Geha
European Journal of Immunology|August 1, 1994
Decreased expression of the ligand for CD40 in newborn lymphocytesR Fuleihan, D Ahern, R S Geha
Clinical Immunology and Immunopathology|July 1, 1995
CD40 ligand expression is developmentally regulated in human thymocytesR Fuleihan, D Ahern, R S Geha
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Protein tyrosine phosphorylation induced via the IgG receptors Fc gamma Ri and Fc gamma RII in the human monocytic cell line THP-1P R Scholl, D Ahern, R S Geha
Allergy|February 12, 2009
Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25- T cells from atopic and nonatopic donorsD Ahern, C M Lloyd, D S Robinson
Physician Executive|February 24, 2001
From primary care physician employment to private practice: easing the transitionC E Holm, D L Glaser, D Ahern
Molecular Pharmacology|April 1, 1994
Identification and characterization of a lysophosphatidic acid receptorF J Thomson, L Perkins, D Ahern, et al.
British Journal of Clinical Pharmacology|June 1, 1997
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2S E Ball, D Ahern, J Scatina, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|August 1, 1979
Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disordersB Cooper, D Ahern
The Journal of Experimental Biology|July 9, 2003
Regulation of urine reprocessing in the maintenance of sodium and water balance in the terrestrial Christmas Island red crab Gecarcoidea natalis investigated under field conditionsStephen Morris, Mark D Ahern
International Archives of Allergy and Immunology|May 1, 1995
Expression of the CD40 ligand in T lymphocytes and induction of IgE isotype switchingR Fuleihan, D Ahern, R S Geha
European Journal of Immunology|August 1, 1994
Decreased expression of the ligand for CD40 in newborn lymphocytesR Fuleihan, D Ahern, R S Geha
Clinical Immunology and Immunopathology|July 1, 1995
CD40 ligand expression is developmentally regulated in human thymocytesR Fuleihan, D Ahern, R S Geha
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Protein tyrosine phosphorylation induced via the IgG receptors Fc gamma Ri and Fc gamma RII in the human monocytic cell line THP-1P R Scholl, D Ahern, R S Geha
Allergy|February 12, 2009
Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25- T cells from atopic and nonatopic donorsD Ahern, C M Lloyd, D S Robinson
Physician Executive|February 24, 2001
From primary care physician employment to private practice: easing the transitionC E Holm, D L Glaser, D Ahern
Molecular Pharmacology|April 1, 1994
Identification and characterization of a lysophosphatidic acid receptorF J Thomson, L Perkins, D Ahern, et al.
British Journal of Clinical Pharmacology|June 1, 1997
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2S E Ball, D Ahern, J Scatina, et al.
Pageof 4